Cite
MLA Citation
Remon Abu-Elyazeed et al.. “Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study.” Human vaccines & immunotherapeutics, vol. 14, no. 11, 2018, pp. 2624–2631. http://access.bl.uk/ark:/81055/vdc_100075228939.0x000006